UB
ADMA icon

UMB Bank’s ADMA Biologics ADMA Stock Holding History

UMB Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
1,277
+700
+121% +$6.38K ﹤0.01% 1918
2026
Q1 		$5.2K Sell
577
-569
-50% -$8.98K ﹤0.01% 2031
2025
Q4 		$20.9K Buy
1,146
+239
+26% +$4.03K ﹤0.01% 1546
2025
Q3 		$13.3K Buy
907
+151
+20% +$2.59K ﹤0.01% 1571
2025
Q2 		$13.8K Buy
756
+89
+13% +$1.81K ﹤0.01% 1496
2025
Q1 		$13.2K Buy
667
+279
+72% +$4.83K ﹤0.01% 1453
2024
Q4 		$6.65K Sell
388
-93
-19% -$1.75K ﹤0.01% 1608
2024
Q3 		$9.62K Buy
+481
New +$7.48K ﹤0.01% 1502

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UMB Bank's ADMA Position: Q2 2026 in Review

UMB Bank increased its ADMA Biologics (ADMA) stake by 121% in Q2 2026, buying an estimated $6.38K and bringing the position to 1,277 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1918.

UMB Bank first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $20.9K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • UMB Bank held 1,277 shares of ADMA Biologics worth $10.7K as of Q2 2026.
  • UMB Bank bought 700 ADMA Biologics shares in Q2 2026, an estimated $6.38K.
  • ADMA Biologics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1918 holding.
  • UMB Bank first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • UMB Bank's ADMA Biologics position peaked at $20.9K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.